Winnow Wealth
UTHR icon

Winnow Wealth’s United Therapeutics UTHR Stock Holding History

Winnow Wealth’s Portfolio UTHR Stock Details UTHR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$892K Sell
1,646
-130
-7% -$67.2K 0.59% 55
2026
Q2 		$962K Sell
1,776
-48
-3% -$27K 0.65% 45
2026
Q1 		$1.08M Sell
1,824
-148
-8% -$73.7K 0.83% 28
2025
Q4 		$962K Buy
+1,972
New +$918K 0.71% 43

Other funds holding UTHR

AssetMark Inc
AssetMark Inc Concord, California $59.5B AUM 15.92% 1-Year Est. Return
Robeco Institutional Asset Management
Robeco Institutional Asset Management Rotterdam, Netherlands $83.2B AUM 35.34% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $103B AUM 40.17% 1-Year Est. Return
Atwood & Palmer
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
KBC Group
KBC Group Brussels, Belgium $47.9B AUM 37.61% 1-Year Est. Return
Polaris Capital Management
Polaris Capital Management Boston, Massachusetts $953M AUM 27.74% 1-Year Est. Return
New York State Teachers Retirement System (NYSTRS)
New York State Teachers Retirement System (NYSTRS) Albany, New York $52.9B AUM 36.03% 1-Year Est. Return
Fjarde Ap-fonden
Fjarde Ap-fonden Stockholm, Sweden $19.4B AUM 31.69% 1-Year Est. Return
Livforsakringsbolaget Skandia
Livforsakringsbolaget Skandia Stockholm, Sweden $3.02B AUM 43.19% 1-Year Est. Return
Nepsis Inc
Nepsis Inc Minneapolis, Minnesota $317M AUM 37.22% 1-Year Est. Return

Winnow Wealth's UTHR Position: Q3 2026 in Review

Winnow Wealth reduced its United Therapeutics (UTHR) stake by 7.3% in Q3 2026, selling an estimated $67.2K and leaving 1,646 shares worth $892K. The position accounts for 0.59% of the portfolio, ranked #55.

Winnow Wealth first reported a position in UTHR in Q4 2025 and has held it in 4 quarters since. The position peaked at $1.08M in Q1 2026. 152 funds tracked by Wall St. Rank hold UTHR as of Q3 2026.

  • Winnow Wealth held 1,646 shares of United Therapeutics worth $892K as of Q3 2026.
  • Winnow Wealth sold 130 United Therapeutics shares in Q3 2026, an estimated $67.2K.
  • United Therapeutics made up 0.59% of Winnow Wealth's portfolio in Q3 2026, its #55 holding.
  • Winnow Wealth first reported a position in United Therapeutics in Q4 2025 and has held it in 4 quarters since.
  • Winnow Wealth's United Therapeutics position peaked at $1.08M in Q1 2026.
  • 152 funds tracked by Wall St. Rank held United Therapeutics as of Q3 2026.

Based on Winnow Wealth's 13F filing for Q3 2026, filed 15 Oct 2026.